CXS chemgenex pharmaceuticals ltd

Ann: FDA agrees on potential regulatory pathway f, page-3

  1. 550 Posts.
    re: Ann: FDA agrees on potential regulatory p... Good news is that they will be rolling up another indication for Omapro which will increase the potential market significantly.

    Not just for T315I mutation but also failure to multiple TKIs.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.